Literature DB >> 17681709

Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results.

Gustavo S Oderich1, Timothy M Sullivan, Thomas C Bower, Peter Gloviczki, Dylan V Miller, Dudica Babovic-Vuksanovic, Thanila A Macedo, Anthony Stanson.   

Abstract

PURPOSE: Neurofibromatosis type I (NF-I) is an autosomal dominant disorder affecting one in 3000 individuals. Vascular abnormalities are a well-recognized manifestation of NF-I. The purpose of this study is to review the spectrum, management, and clinical outcome of patients with vascular abnormalities and NF-I.
METHODS: We retrospectively reviewed 31 patients (15 males, 16 females) with clinical NF-I and vascular abnormalities identified from imaging or operative findings between 1976 and 2005.
RESULTS: The diagnosis of NF-I was made at a mean age of 11 +/- 10 years with vascular lesions identified at a mean age of 38 +/- 16 years. There were 76 vascular abnormalities, including 38 aneurysms, 20 arterial stenoses, 5 arteriovenous malformations (AVM), 5 arteries compressed or invaded by neural tumors, and 6 abnormalities of the heart valves. Arterial lesions were located in the aorta (n = 17) and in the renal (n = 12), mesenteric (n = 12), carotid-vertebral (n = 10), intracerebral (n = 4), and subclavian-axillary and iliofemoral arteries (3 each). Interventions were required in 23 patients (74%); 15 underwent 24 arterial reconstructions, including 9 renal, 8 aortic, 4 mesenteric, 2 carotid, and 1 femoral. The other eight patients had excision of AVM in three, vessel ligation in two, and clipping of cerebral aneurysms, coil embolization of hepatic aneurysms, and left thoracotomy in one patient each. One patient died of ruptured abdominal aortic aneurysm. Six patients (26%) had postoperative complications, including pneumonia in two, and stroke, acalculous cholecystitis, brachial plexopathy and chylothorax in one patient each. The median follow up was 4.1 years (range, 6 months to 20 years). Late vascular problems developed in three patients, including graft stenoses in two and rupture of another aortic aneurysm in one. Freedom from graft-related complications was 83% at 10 years. Patient survival at 10 years was 77%, less than the 86% expected survival for the general population (P < .001).
CONCLUSION: Patients with NF-I have a wide spectrum of vascular abnormalities, most notably aneurysms or stenoses of the aortic, renal, and mesenteric circulation. Operative treatment of symptomatic patients with vascular lesions or large aneurysms is safe, effective, and durable.

Entities:  

Mesh:

Year:  2007        PMID: 17681709     DOI: 10.1016/j.jvs.2007.03.055

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  86 in total

1.  Current concepts in the management of chronic mesenteric ischemia.

Authors:  Gustavo S Oderich
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-04

2.  Perioperative management of neurofibromatosis type 1.

Authors:  Charles J Fox; Samir Tomajian; Aaron J Kaye; Stephanie Russo; Jacqueline Volpi Abadie; Alan D Kaye
Journal:  Ochsner J       Date:  2012

Review 3.  An update on the central nervous system manifestations of neurofibromatosis type 1.

Authors:  J Stephen Nix; Jaishri Blakeley; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2019-04-08       Impact factor: 17.088

4.  Revascularization in a 17-Year-Old Girl with Neurofibromatosis and Severe Hypertension Caused by Renal Artery Stenosis.

Authors:  Carmen C Beladan; Oliviana D Geavlete; Simona Botezatu; Marin Postu; Bogdan A Popescu; Carmen Ginghina; Ioan M Coman
Journal:  Tex Heart Inst J       Date:  2017-02-01

5.  Fatal acute retropharyngeal hemorrhage in neurofibromatosis type 1.

Authors:  Pierre-Antoine Peyron; Michael S Pollanen
Journal:  Forensic Sci Med Pathol       Date:  2017-10-28       Impact factor: 2.007

6.  Spontaneous subclavian artery rupture in neurofibromatosis type I.

Authors:  Vasileios Souftas; Georgios Tsivgoulis; Michalis Kirmanidis; Konstantinos Vadikolias; Charitomeni Piperidou; Panos Prassopoulos
Journal:  Neurol Sci       Date:  2011-06-08       Impact factor: 3.307

7.  Neurofibromatosis 1 vasculopathy manifesting as a peripheral aneurysm in an adolescent.

Authors:  Shannon G Farmakis; Min Han; Frances White; Geetika Khanna
Journal:  Pediatr Radiol       Date:  2014-04-27

8.  Spontaneous massive hemothorax in a patient with neurofibromatosis type 1 with successful transarterial embolization.

Authors:  Keerati Hongsakul; Sorracha Rookkapan; Pramot Tanutit; Songklod Pakdeejit; Apiradee Songjamrat; Jitpreedee Sungsiri
Journal:  Korean J Radiol       Date:  2012-12-28       Impact factor: 3.500

9.  Renal artery stenosis due to neurofibromatosis.

Authors:  Ishwar Chandra Malav; S S Kothari
Journal:  Ann Pediatr Cardiol       Date:  2009-07

10.  Neurofibromatosis type 1 and multiple traumatic cervical arterial injuries: a case report.

Authors:  Bertrand Sauneuf; Stéphanie Chevalier; Claude Jehan; Patrick Courtheoux; Jean-Louis Gérard; Jean-Luc Hanouz; Benoit Plaud
Journal:  Cases J       Date:  2009-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.